Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition

Gastro-Intestinal Tolerance Clinical Trial

Official title:
A Study to Evaluate the Gastrointestinal Tolerance and Acceptability of a High Energy, High Protein Low Volume Oral Nutritional Supplement in Adult Patients With or at Risk of Malnutrition

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the GI tolerance, palatability and compliance to a high protein energy-dense oral nutrition supplement in adult patients with or at risk of malnutrition.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04259437
Study type	Interventional
Source	Abbott Nutrition
Contact
Status	Completed
Phase	N/A
Start date	March 10, 2020
Completion date	May 11, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03293706` - Evaluation of Carbohydrates Part 2	N/A
Completed	`NCT01781624` - Evaluation of an Oral Nutritional Supplement	N/A
Completed	`NCT01782456` - Tolerance of an Oral Nutritional Supplement(ONS)	N/A
Completed	`NCT03967132` - Growth and Tolerance of Infants Fed Milk-Based Infant Formula	N/A
Terminated	`NCT04934397` - Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula	N/A
Completed	`NCT04915937` - Formula Tolerance of Term Infants	N/A
Withdrawn	`NCT04104815` - GI Tolerance and Acceptability of a New Thickener	N/A